These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 25522783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB, Yang DP, Wen XD, Chen XJ, Zhang L, Wu LL, Bie P, Xia F.
    J Exp Clin Cancer Res; 2017 Jun 24; 36(1):86. PubMed ID: 28646927
    [Abstract] [Full Text] [Related]

  • 3. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L, Tung-Ping Poon R, Yau S, Chow A, Lam C, Li HS, Chung-Cheung Yau T, Law WL, Pang R.
    Hepatology; 2013 Aug 24; 58(2):667-79. PubMed ID: 23504997
    [Abstract] [Full Text] [Related]

  • 4. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H.
    J Transl Med; 2017 Aug 15; 15(1):176. PubMed ID: 28810875
    [Abstract] [Full Text] [Related]

  • 5. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH, Guo ZY, Chen ZT, Zhi XT, Li DK, Dong ZR, Chen ZQ, Hu SY, Li T.
    Sci Rep; 2015 Jul 20; 5():12366. PubMed ID: 26190376
    [Abstract] [Full Text] [Related]

  • 6. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S, Chang RM, Yang MY, Lei X, Liu X, Gao WB, Xiao JL, Yang LY.
    Hepatology; 2016 Apr 20; 63(4):1256-71. PubMed ID: 26698646
    [Abstract] [Full Text] [Related]

  • 7. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
    He F, Li J, Xu J, Zhang S, Xu Y, Zhao W, Yin Z, Wang X.
    J Exp Clin Cancer Res; 2015 May 15; 34(1):47. PubMed ID: 25975202
    [Abstract] [Full Text] [Related]

  • 8. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.
    Biomed Pharmacother; 2017 Apr 15; 88():421-429. PubMed ID: 28122307
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
    Chen HC, Jeng YM, Yuan RH, Hsu HC, Chen YL.
    Ann Surg Oncol; 2012 Jun 15; 19(6):2011-9. PubMed ID: 22146883
    [Abstract] [Full Text] [Related]

  • 11. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J.
    Cancer Lett; 2015 Mar 28; 358(2):124-135. PubMed ID: 25462858
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S, Yang C, Yu F, Ding W, Hu Y, Cheng F, Zhang F, Guan B, Wang X, Lu L, Rao J.
    Cell Death Dis; 2018 Oct 30; 9(11):1105. PubMed ID: 30377291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
    Pan Y, Wang B, Yang X, Bai F, Xu Q, Li X, Gao L, Ma C, Liang X.
    Sci Rep; 2015 Nov 23; 5():17006. PubMed ID: 26593394
    [Abstract] [Full Text] [Related]

  • 19. Tiam1 is associated with hepatocellular carcinoma metastasis.
    Huang J, Ye X, Guan J, Chen B, Li Q, Zheng X, Liu L, Wang S, Ding Y, Ding Y, Chen L.
    Int J Cancer; 2013 Jan 01; 132(1):90-100. PubMed ID: 22573407
    [Abstract] [Full Text] [Related]

  • 20. JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
    Tang B, Qi G, Tang F, Yuan S, Wang Z, Liang X, Li B, Yu S, Liu J, Huang Q, Wei Y, Zhai R, Lei B, Yu H, Jiao X, He S.
    Oncotarget; 2015 May 20; 6(14):12723-39. PubMed ID: 25909289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.